Antacids are an important part of many first aids and life support treatments. Most antacids used for acid reflux and heartburn are established to neutralize stomach acids, which can damage the esophageal mucosa, especially if taken for a prolonged period. However, despite this, and other facts, the medical literature continues to describe cases where antacids have actually been shown to increase the rate of new ulcerative colitis.
Antacid medications can be administered to people with digestive problems, and they have a role to play in the management of most digestive disorders. However, antacids do not directly treat any digestive or postprandial conditions. But some of these over-the-counter medications can serve a useful role as adjunctive (additional supportive) treatments to prevent the weakening of the esophageal mucosa, especially of the stomach's lining. In some instances, doctors have recommended the use of these medications in the treatment of conditions that are not associated with a physiological cause that could suggest an inappropriate treatment, such as those that occur after surgery (decortication).
Antacid prescription medications can also be used to treat acid reflux, but their effect on the symptoms of acid reflux depends upon their dosage and the strength of the drug. Very weak antacid medications can create rebound hyper acid reflux symptoms that can worsen the condition instead of ameliorating it. Stronger acid reflux medications such as H2 blockers can actually prevent the acid reflux that is caused by the excessive production of digestive acid by closing the opening between the stomach and the esophagus. H2 blockers reduce the acid that causes damage to the esophagus and the lining of its lining. The combination of antacids and secondary adverse effects of NSAIDs might make them less desirable than the conventional treatments for acid reflux.
Antacids are the most commonly used product for treating heartburn discomfort.
And because they start to work in seconds, they’re also the fastest way to relieve your symptoms.
Available without a prescription, antacids are available in convenient chewable tablets or as a liquid.The global average price of Antacid is in the decreasing trend, from 11.43 USD/Unit in 2013 to 10.73 USD/Unit in 2017.
With the situation of global economy, prices will be in decreasing trend in the following five years.The classification of Antacid includes Proton Pump Inhibitor, H2 Antagonist and Acid Neutralizers, and the proportion of Proton Pump Inhibitor in 2017 is about 39%.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-antacid-2019-2024-542According to this study, over the next five years the Antacid market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 6300 million by 2024, from US$ 6120 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in Antacid business, shared in Chapter 3.This report presents a comprehensive overview, market shares, and growth opportunities of Antacid market by product type, application, key manufacturers and key regions and countries.This study considers the Antacid value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.Proton Pump InhibitorH2 AntagonistAcid NeutralizersSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.OTC DrugRx DrugThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeGermanyFranceUKItalyRussiaSpainMiddle East & AfricaEgyptSouth AfricaIsraelTurkeyGCC CountriesThe report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.
The key manufacturers covered in this report: Breakdown data in in Chapter 3.AstraZenecaTakeda PharmaceuticalPfizerReckitt BenckiserBayerProcter?GambleGlaxoSmithKlineJohnson?JohnsonCONBAXiuzheng PharmaSanofiBausch HealthCR SANJIUReddy’s LaboratoriesResearch objectives:To study and analyze the global Antacid consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.To understand the structure of Antacid market by identifying its various subsegments.Focuses on the key global Antacid manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Antacid with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the consumption of Antacid submarkets, with respect to key regions (along with their respective key countries).To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-antacid-2019-2024-542Table of content1 Scope of the Report1.1 Market Introduction1.2 Research Objectives1.3 Years Considered1.4 Market Research Methodology1.5 Economic Indicators1.6 Currency Considered2 Executive Summary2.1 World Market Overview2.1.1 Global Antacid Consumption 2014–20242.1.2 Antacid Consumption CAGR by Region2.2 Antacid Segment by Type2.2.1 Proton Pump Inhibitor2.2.2 H2 Antagonist2.2.3 Acid Neutralizers2.3 Antacid Consumption by Type2.3.1 Global Antacid Consumption Market Share by Type (2014–2019)2.3.2 Global Antacid Revenue and Market Share by Type (2014–2019)2.3.3 Global Antacid Sale Price by Type (2014–2019)2.4 Antacid Segment by Application2.4.1 OTC Drug3 Global Antacid by Players3.1 Global Antacid Sales Market Share by Players3.1.1 Global Antacid Sales by Players (2017–2019)3.1.2 Global Antacid Sales Market Share by Players (2017–2019)3.2 Global Antacid Revenue Market Share by Players3.2.1 Global Antacid Revenue by Players (2017-CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
The statistical surveying report on the global Antacid Market has been presented by using professional or expert knowledge through standard and modified research approaches and forecasts.
The yearly forecast and predication for the years 2020 to 2025 have been enclosed by the report along with comprehensive analysis for all market segments and regions.
The statistical data derived from authentic resources and assisted by industry experts.
It likewise assesses the market by evaluating market elements, including drivers, restraints, opportunities, threats, challenges, growth prospects, and other market elements.
The global antacid market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform.
Get FREE Sample Report Copy https://www.decisiondatabases.com/contact/download-sample-43717 According to this study, over the next five years, the Antacid market will register a 0.8% CAGR in terms of revenue, the global market size will reach $ 6295 million by 2025, from $ 6090.3 million in 2019.
